New research indicates that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who halt traditional diet and exercise plans.
Published data in a major health publication points out that while overweight individuals often shed a large proportion of their body weight while undergoing treatment, the weight returns at an average rate of nearly a kilo each month once they quit.
"People buying these treatments should be aware of the potential of fast rebound weight gain when the treatment is stopped," cautioned expert Dr. Susan Jebb.
Such speed of regain means a reversion to starting weight within about one and a half years.
Comparing Therapies
The study, which examined 37 of studies involving thousands of patients, compared the effects of GLP-1 agonists with other pills.
Scientists point out that people who shed pounds through diet and exercise generally have a more gradual creep back—around 0.1 kg a month—once they finish.
The Reason for the Rapid Regain
Nutrition scientists believe the mode of action of the jabs explains the heightened regain.
GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Long-term administration of the hormone concentrations far above than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' means appetite is uncontrolled, making binge eating much more probable."
A Chronic Condition?
Health authorities suggest the jabs for individuals with weight-linked health risks, alongside recommended lifestyle changes.
A number of clinicians argue that, given the likelihood of relapse, the therapy is often ongoing.
This opinion is reinforced by pharmaceutical companies, who note that the findings "highlight the chronic nature of excess weight," akin to managing conditions like hypertension.
Patient Accounts
People who have come off the jabs explain a powerful return of cravings.
"I experienced something that goes on and you become extremely hungry," said one woman.
This challenge is exacerbated if users have not established lasting lifestyle or habit modifications during therapy.
Widespread Use
Recent estimates suggest that millions of adults in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Use is greater among females compared to males.
- The middle-aged demographic shows the greatest usage rates.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while GLP-1 drugs are powerful tools for weight loss, they are not a standalone cure and maintained weight loss likely depends on combined lifestyle changes.